Lindbrook Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$60.8K Buy
1,646
+998
+154% +$35.6K 0.01% 909
2024
Q4
$21.6K Buy
648
+28
+5% +$908 ﹤0.01% 1244
2024
Q3
$16.1K Buy
620
+6
+1% +$149 ﹤0.01% 1410
2024
Q2
$13.8K Sell
614
-240
-28% -$5.32K ﹤0.01% 1453
2024
Q1
$20.3K Sell
854
-136
-14% -$3.02K ﹤0.01% 1203
2023
Q4
$23.8K Buy
990
+263
+36% +$5.72K ﹤0.01% 1088
2023
Q3
$15.9K Sell
727
-19
-3% -$397 ﹤0.01% 1178
2023
Q2
$14.3K Buy
746
+51
+7% +$983 ﹤0.01% 1263
2023
Q1
$13.5K Buy
695
+660
+1,886% +$11.5K ﹤0.01% 1268
2022
Q4
$561 Buy
+35
New +$571 ﹤0.01% 2575
2022
Q2
Sell
-16
Closed 2564
2022
Q1
$0 Buy
+16
New +$313 ﹤0.01% 2517
2021
Q4
Sell
-37
Closed -$1K 2114
2021
Q3
$1K Sell
37
-180
-83% -$3.34K ﹤0.01% 1711
2021
Q2
$4K Hold
217
﹤0.01% 1357
2021
Q1
$5K Buy
217
+22
+11% +$497 ﹤0.01% 1251
2020
Q4
$4K Buy
+195
New +$4.08K ﹤0.01% 1249

Other funds holding EXEL

Lindbrook Capital's EXEL Position: Q1 2025 in Review

Lindbrook Capital increased its Exelixis (EXEL) stake by 154% in Q1 2025, buying an estimated $35.6K and bringing the position to 1,646 shares worth $60.8K. The position accounts for 0.01% of the portfolio, ranked #909.

Lindbrook Capital first reported a position in EXEL in Q4 2020 and has held it in 15 quarters since. 558 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.

  • Lindbrook Capital held 1,646 shares of Exelixis worth $60.8K as of Q1 2025.
  • Lindbrook Capital bought 998 Exelixis shares in Q1 2025, an estimated $35.6K.
  • Exelixis made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #909 holding.
  • Lindbrook Capital first reported a position in Exelixis in Q4 2020 and has held it in 15 quarters since.
  • 558 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.